Legal Status of Mutually Recognised Authorisation after Brexit
VerifiedAdded on 2022/10/17
|28
|7730
|164
AI Summary
This article discusses the legal status of mutually recognised authorisation after Brexit, specifically in the case where the UK is the reference member state. It covers the principles and legal basis of Brexit, the European Union regulatory system for medicines, and the impact of a no-deal Brexit on the pharmaceutical industry.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.